Is your New Drug Application (NDA) submission on track?
Throughout our years supporting FDA submissions, Premier Research has seen firsthand that many NDA and BLA filing delays are not caused by the submission itself, but by critical activities that begin too late. Sponsors often underestimate the time and coordination required for key pre-filing requirements, creating unnecessary risk as filing milestones approach.
This guide highlights the requirements that are most frequently misunderstood and the planning needed to avoid common pitfalls. From CMC readiness and document management to labeling, ClinicalTrials.gov compliance, and other essential pre-filing activities, you’ll gain practical insights to help keep your submission on schedule and prepare for a successful NDA or BLA filing.